Fresenius's Sale of Part of Fresenius Medical Care Stake Is Positive -- Market Talk

Dow Jones
03-04

0935 GMT - Fresenius's sale of a portion of its stake in Fresenius Medical Care is a positive step that gives the former a source of funds to reduce debt and continue its strategy, Jefferies analysts say in a research note. German healthcare company Fresenius's 32.2% stake in Fresenius Medical Care has loomed over both companies, according to Jefferies. Fresenius cut its stake in the dialysis business to just above 25% by selling a 3.6% stake and a 600 million-euro bond exchangeable for an additional 3.5% stake, raising 1.1 billion euros in total. Shares in Fresenius Medical Care drop 7.1% to 44.10 euros, below the 44.50 euro level at which Fresenius sold the stake. Fresenius shares fall 0.6%. (adria.calatayud@wsj.com)

 

(END) Dow Jones Newswires

March 04, 2025 04:35 ET (09:35 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10